Sean Bohen
2020
In 2020, Sean Bohen earned a total compensation of $10.6M as President and Chief Executive Officer at Olema Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $109,160 |
|---|---|
| Option Awards | $10,311,362 |
| Salary | $177,977 |
| Total | $10,598,498 |
Bohen received $10.3M in option awards, accounting for 97% of the total pay in 2020.
Bohen also received $109.2K in non-equity incentive plan and $178K in salary.
Rankings
In 2020, Sean Bohen's compensation ranked 763rd out of 13,090 executives tracked by ExecPay. In other words, Bohen earned more than 94.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 763 out of 13,090 | 94th |
Division Manufacturing | 265 out of 5,621 | 95th |
Major group Chemicals And Allied Products | 84 out of 2,254 | 96th |
Industry group Drugs | 73 out of 1,954 | 96th |
Industry Pharmaceutical Preparations | 56 out of 1,459 | 96th |
Source: SEC filing on April 27, 2021.
Bohen's colleagues
We found three more compensation records of executives who worked with Sean Bohen at Olema Pharmaceuticals in 2020.